New Technion research will advance a solution to strokes caused by a blockage of a major brain artery — known as a large vessel occlusion (LVO) — which are medical emergencies. If treatment is delayed, the consequences can be devastating: severe brain damage, disability, or death.
Last week, the Technion marked 25 years since the invention of the portable storage device – the Disk On Key – in a special event with Technion alumnus Dov Moran, the inventor of the USB flash drive.
Technion Researchers reveal complex interactions between heart disease and cancer, in the hope that their findings will lead to improved treatment for both conditions.
According to researchers at the Technion – Israel Institute of Technology, the future of energy lies in technological breakthroughs in porous materials, whose influence extends across diverse fields – from computing systems to biomedical engineering. Published in Science, their findings present a long-term roadmap for the evolution of the energy sector.
Technion Australia’s Einstein Supper in Melbourne explored the true environmental, material, and financial costs of Australia’s net-zero transition, featuring expert insights from Dr Rod Hill.
Thinking about where to study for a thriving career? Discover why the Technion stands out: leading‑edge programs, real‑world innovation, and access to global opportunities that help ambitious students succeed.
The Technion has awarded the Harvey Prize to two leading American scientists whose breakthroughs in nanotechnology and medicine are shaping the future of global research and innovation.
Technion Australia joined forces with Moriah College for a groundbreaking hackathon that blended high-tech innovation with Jewish identity – empowering students to build meaningful tech solutions and forge deeper ties to Israel.
The Ruth and Bruce Rappaport Faculty of Medicine inaugurated a new complex for its Teaching and Medical Education Division, established through the generous contribution of Professor Emeritus John Finberg — one of the faculty’s veterans and a co-developer of the first-ever drug shown to slow the progression of Parkinson’s disease.
Former German Chancellor Dr Angela Merkel visited the Technion, meeting students and researchers, touring key labs, and highlighting the deep scientific partnership between Israel and Germany.
Technion scientists unveil a fast-acting bio-glue that bonds wet tissues in seconds—reducing bleeding, infections and the need for stitches.
The Technion has been awarded 5.75 million NIS in Mavri grants to develop engineered tissues aimed at heart rehabilitation and improving treatments for juvenile diabetes.
